3 ms·
I'm wondering why we don't start producing mRNA vaccines targeting this other variant now. Seems like there could be some safety and efficacy protocol put in pl
by derbOac 5y ago
I'm wondering why we don't start producing mRNA vaccines targeting this other variant now. Seems like there could be some safety and efficacy protocol put in place to target emerging variants so we don't have to start from scratch in the approval process, requiring 30k-40k adults alone every year.
- M2Ys4U 5y ago>I'm wondering why we don't start producing mRNA vaccines targeting this other variant now. People are developing mRNA vaccines for 'flu now. Moderna, Pfizer and Sanofi all have mRNA 'flu vaccines in clinical trials, and there are a bunch more in the pre-clinical stages. https://www.nature.com/articles/d41573-021-00176-7 https://www.nature.com/articles/d41573-021-00176-7